-The Business Standard The Union Budget for 2012-13 today reinforced the importance of Uniquie Identification programme, as the Finance Minister Pranab Mukherjee approved an outlay of around Rs 1,450 crore for Aadhaar. Finance Minister also increased the rollout target for Aadhaar card to an additional 400 million people. The enrolments into the Aadhaar system have already crossed 200 million. “The Aadhaar platform is now ready to support the payments of MGNREGA; old age,...

The common man, whose concerns were at the heart of the Congress-led United Progressive Alliance’s two successful election campaigns, doesn’t seem to be the focus of finance minister Pranab Mukherjee’s budget. Experts and political analysts say the aam admi doesn’t appear to be the dominant concern anymore, prompting speculation about Congress party chief Sonia Gandhi’s role. She has thus far been setting the UPA’s social agenda through the National Advisory Council...

-The Hindu ‘But cumbersome anti-graft apparatus can delay decisions'   With a slew of scams vitiating the government's policy-making environment and holding up reforms, the Economic Survey 2011-12 on Thursday advocated need for a ruthless crackdown on corruption, but cautioned that a large and cumbersome anti-corruption bureaucracy could impact decision-making. “While we need to ruthlessly crack down on corruption, it must, at the same time, be recognised that the fear of a large and...

-The Economic Times The NGOs and experts working in water sector have welcomed the idea of promoting private investment in irrigation sector. "There is need and large scope for participation of private sector in the irrigation sector. The success will however will depend upon how the details are worked out taking views of local people and NGOs into consideration," said Dr Madhav Chitale, former secretary, Ministry of Water Resources.  The Finance Minister...

Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...